dihydroergotamine has been researched along with verapamil in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pratim Roy, P; Roy, K | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Deliganis, AV; Peroutka, SJ | 1 |
Kaplan, B; Swain, RA | 1 |
Magnoux, E; Zlotnik, G | 1 |
Antequera, R; Cedeño, J; Estrada, O; León, L; Romero-Vecchione, E; Rosa, F; Vásquez, J | 1 |
Johnson, BD; Schenkat, DH; Schulz, LT | 1 |
2 review(s) available for dihydroergotamine and verapamil
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Diagnosis, prophylaxis, and treatment of headaches in the athlete.
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Chronic Disease; Cluster Headache; Dihydroergotamine; Female; GABA Agents; Headache; Humans; Male; Migraine Disorders; Nortriptyline; Physical Exertion; Psychomotor Performance; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sports; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil | 1997 |
7 other study(ies) available for dihydroergotamine and verapamil
Article | Year |
---|---|
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Topics: Algorithms; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Factor Analysis, Statistical; Least-Squares Analysis; Linear Models; Models, Molecular; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Reproducibility of Results | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
Topics: Adenylyl Cyclase Inhibitors; Amitriptyline; Animals; Cattle; Caudate Nucleus; Dihydroergotamine; Ergotamine; Indoles; Kinetics; Methysergide; Migraine Disorders; Radioligand Assay; Receptors, Serotonin; Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Verapamil | 1991 |
Outpatient intravenous dihydroergotamine for refractory cluster headache.
Topics: Adult; Aged; Ambulatory Care; Analgesics, Non-Narcotic; Chronic Disease; Cluster Headache; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Verapamil | 2004 |
Cardiovascular excitatory effect on rats of a fraction isolated from the eyestalk of shrimp: Peneaus vanameii.
Topics: Animal Structures; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Calcium Channels; Cardiotonic Agents; Dihydroergotamine; Drug Evaluation, Preclinical; Enalapril; Ganglia, Invertebrate; Heart Rate; Hemodynamics; Hypertension; Male; Motor Neurons; Neuropeptides; Penaeidae; Premedication; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Tachycardia; Tissue Extracts; Verapamil | 2006 |
Dihydroergotamine-induced vasospastic angina in a patient taking a calcium channel blocker.
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Dihydroergotamine; Drug Interactions; Female; Headache; Humans; Hypertension; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Practice Guidelines as Topic; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 2011 |